查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
灌注影像市場：現況分析與預測（2023-2030）
市場調查報告書
商品編碼
1364873

灌注影像市場：現況分析與預測（2023-2030）

Perfusion Imaging Market: Current Analysis and Forecast (2023-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

從 2023 年到 2030 年，灌注影像市場預計複合年增長率約為 4.3%。 灌注影像是一種醫學影像技術，用於評估體內組織和器官的血流量。 它對於診斷和監測中風、心臟病和某些類型的癌症等疾病特別有用。 心血管疾病盛行率的增加推動了灌注影像需求的成長。 例如，根據 CDC 的數據，在美國每 33 秒就有一人死於心血管疾病。 2021年，美國將有約69.5萬人死於心臟病，佔死亡人數的五分之一。 此外，成像技術的持續進步，包括更高解析度和更有效率的成像技術，是關鍵驅動因素。 MRI、CT 和核子醫學的創新正在提高灌注影像能力。 此外，灌注成像在腫瘤學中的腫瘤檢測和評估中發揮重要作用。 全球癌症發生率上升正在推動對灌注成像的需求。 2021 年，癌症仍然是醫療保健領域的關鍵問題。

依類型劃分，市場分為磁振造影、電腦斷層掃描、超音波等。 其中，磁振造影領域由於其非侵入性、卓越的軟組織對比度以及提供定量灌注數據的能力，預計市場將以更高的複合年增長率成長。 MRI 技術的最新發展，加上新的政府法規，進一步促進了這一領域的成長。 例如，2021 年，Siemens Healthineers 推出了 MAGNETOM Free.Max MRI 系統，該系統採用適合神經影像應用的尖端技術。 該系統為神經學評估提供先進的灌注成像功能。

依用途分為通氣灌注造影、心肌灌注造影、腦部功能影像、腫瘤檢測等。 其中，心肌灌注影像領域預計將以更高的複合年增長率成長，因為包括冠狀動脈疾病（CAD）在內的心血管疾病是全球發病和死亡的主要原因。 MPI 在這些疾病的診斷和評估中發揮著重要作用，推動了該領域的需求。 例如，Siemens Healthineers 推出了 syngo.CT Cardiac Function，這是一款旨在使用 CT 掃描評估心臟功能（包括心肌灌注）的軟體應用程式。 儘管這一發展並非特定於使用核醫學的 MPI，但它是業界努力擴展心臟影像功能的一個例子。

根據最終用戶，市場分為醫院、診斷中心和研究機構。 特別是，預計醫院在預測期內將增加灌注影像的採用。 醫院部門是灌注影像市場的主要驅動力，因為灌注影像在醫療保健服務以及各種醫療狀況的診斷和治療中發揮核心作用。 灌注影像對於治療計劃和監測也至關重要。 醫院使用灌注影像來評估醫療狀況的範圍和嚴重程度，並幫助規劃手術、介入和治療。 幫助優化患者照護。 此外，快速、準確的診斷對於中風、心肌梗塞和外傷等緊急情況至關重要。 醫院正在使用灌注成像進行快速評估，從而能夠及時採取乾預措施，挽救生命並降低發病率。 例如，世界各地的許多醫院將在 2021 年繼續擴大其診斷影像部門並使其現代化。 我們投資了先進的灌注影像系統，包括 MRI、CT 和 PET 掃描儀，以提高病患照護和診斷能力。

為了更了解ADNP症候群治療產業的市場介紹，將市場分為北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、西班牙、義大利、歐洲其他地區） 、亞太地區（根據其他地區（中國、日本、印度、亞太其他地區）和其他地區的全球影響力進行分析。 由於癌症發病率不斷上升、醫療保健專業人員和公眾對灌注成像的認識不斷提高、先進影像處理技術的市場發展以及治療選擇的數量不斷增加，北美灌注成像市場將繼續增長。 例如，根據美國癌症協會的數據，2020 年，癌症是美國僅次於心臟病的第二大死因。 預計 2022 年美國將有約 609,360 人死於癌症，相當於每天約 1,670 人死亡。

目錄

第一章市場介紹

  • 市場定義
  • 主要目標
  • 利害關係人
  • 限制

第二章研究方法或假設

  • 調查過程
  • 調查方法
  • 受訪者簡介

第三章市場總結

第 4 章執行摘要

第 5 章 COVID-19 對灌注造影市場的影響

第 6 章 2020-2030 年全球灌注影像市場收入

第 7 章按類型劃分的市場洞察

  • 磁振造影
  • 電腦斷層掃描
  • 超音波
  • 其他

第 8 章按應用劃分的市場洞察

  • 通氣灌注成像
  • 心肌灌注成像
  • 腦功能影像
  • 腫瘤檢測

第 9 章最終使用者的市場洞察

  • 醫院和診所
  • 診斷中心
  • 調查機構

第 10 章按地區劃分的市場洞察

  • 北美灌注造影市場
    • 美國
    • 加拿大
    • 其他北美地區
  • 歐洲灌注造影市場
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲地區
  • 亞太灌注造影市場
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 其他地區的灌注影像市場

第 11 章灌注成像市場動態

  • 市場驅動因素
  • 市場挑戰
  • 影響分析

第 12 章灌注影像市場機會

第 13 章灌注影像市場趨勢與見解

第14章需求面與供給面分析

  • 需求方分析
  • 供給面分析

第 15 章價值鏈分析

第16章價格分析

第十七章競爭場景

  • 競爭狀況
    • 波特五力分析

第十八章公司簡介

  • Siemens Healthineers
  • GE Healthcare,
  • Philips Healthcare
  • Bayer AG
  • Medtronic
  • Canon Medical Systems Corporation
  • Shimadzu Corporation
  • Bracco Imaging S.p.A
  • Neusoft Corporation
  • Perimed AB

第十九章免責聲明

簡介目錄
Product Code: UMHE212350

The perfusion imaging market is expected to register a CAGR of approx. 4.3% over the period of 2023-2030. Perfusion imaging is a medical imaging technique used to assess blood flow to tissues and organs in the body. It is particularly valuable in diagnosing and monitoring conditions such as stroke, heart disease, and certain types of cancer. The growing demand for perfusion imaging can be attributed to the increasing incidence of cardiovascular diseases are the key factors which boost the adoption around the globe. For instance, according to the CDC, One person dies every 33 seconds in the United States from cardiovascular disease. About 695,000 people in the United States died from heart disease in 2021-that's 1 in every 5 deaths. Furthermore, ongoing advancements in imaging technology, including higher resolution and more efficient imaging techniques, have been a key driver. Innovations in MRI, CT, and nuclear medicine have enhanced the capabilities of perfusion imaging. Moreover, perfusion imaging plays a crucial role in oncology for the detection and evaluation of tumours. The rising incidence of cancer cases worldwide has driven the demand for perfusion imaging procedures. In 2021, cancer remained a significant healthcare concern.

Based on the type, the market has been categorized into magnetic resonance imaging, computed tomography, ultrasound, and others. Among them, the magnetic resonance imaging segment is expected to grow at a higher CAGR in the market due to its non-invasive nature, excellent soft tissue contrast, and ability to provide quantitative perfusion data. Recent developments in MRI technology, combined with new government regulations, have further contributed to the growth of this segment. For instance, in 2021, Siemens Healthineers introduced the MAGNETOM Free.Max MRI system, which features cutting-edge technology for neuroimaging applications. This system offers advanced perfusion imaging capabilities for neurological assessments.

Based on the application, the market has been categorized into ventilation-perfusion imaging, myocardial perfusion imaging, functional brain imaging, and tumour detection. Among them, the myocardial perfusion imaging segment is expected to grow at a higher CAGR in the market due to Cardiovascular diseases, including coronary artery disease (CAD), are a leading cause of morbidity and mortality worldwide. MPI plays a crucial role in diagnosing and evaluating these conditions, driving demand for this segment. For instance, Siemens Healthineers introduced the syngo.CT Cardiac Function, a software application designed to assess cardiac function, including myocardial perfusion, using CT scans. While this development is not specific to MPI using nuclear medicine, it exemplifies the industry's efforts to expand the capabilities of cardiac imaging.

Based on the end-user, the market has been categorized into hospitals, diagnostic center, and research institutes. Among them, the hospital category is to witness higher adoption of perfusion imaging during the forecast period. The hospitals segment is a key driver of the perfusion imaging market due to its central role in healthcare delivery and the diagnosis and treatment of various medical conditions. In addition, Perfusion imaging is crucial for treatment planning and monitoring. Hospitals use perfusion imaging to assess the extent and severity of conditions, which helps in planning surgeries, interventions, and therapies. It aids in optimizing patient care. Moreover, In emergency situations such as stroke, myocardial infarction, and trauma, quick and accurate diagnosis is critical. Hospitals use perfusion imaging for rapid assessment, enabling timely interventions that can save lives and reduce morbidity. For example, Many hospitals worldwide continued to expand and modernize their imaging departments in 2021. They invested in advanced perfusion imaging systems, such as MRI, CT, and PET scanners, to improve patient care and diagnostic capabilities.

For a better understanding of the market adoption of the ADNP syndrome treatment industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. The North America perfusion imaging market is expected to continue to grow in the coming years, driven by the increasing prevalence of cancer and growing awareness of perfusion imaging among healthcare professionals and the general population, development of advanced imaging techniques and the rise in treatment option. For instance, in 2020, according to American Cancer Society, Cancer is the second most common cause of death in the US, exceeded only by heart disease. around 609,360 deaths from cancer are expected in the US in 2022, which is about 1,670 deaths per day.

Some of the major players operating in the market include: Siemens Healthineers, GE Healthcare, Philips Healthcare, Bayer AG, Medtronic, Canon Medical Systems Corporation, Shimadzu Corporation, Bracco Imaging S.p.A, Neusoft Corporation, Perimed AB.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Perfusion Imaging Market
  • 2.2. Research Methodology of the Perfusion Imaging Market
  • 2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE PERFUSION IMAGING MARKET

6 GLOBAL PERFUSION IMAGING MARKET REVENUE, 2020-2030F

7 MARKET INSIGHTS BY TYPE

  • 7.2. Magnetic Resonance Imaging
  • 7.3. Computed Tomography
  • 7.4. Ultrasound
  • 7.5. Others

8 MARKET INSIGHTS BY APPLICATION

  • 8.1. Ventilation Perfusion Imaging
  • 8.2. Myocardial Perfusion Imaging
  • 8.3. Functional Brain Imaging
  • 8.5. Tumor Detection

9 MARKET INSIGHTS BY END-USERS

  • 9.1. Hospitals and Clinics
  • 9.2. Diagnostic Center
  • 9.3. Research Institutes

10 MARKET INSIGHTS BY REGION

  • 10.1 NORTH AMERICA PERFUSION IMAGING MARKET
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of North America
  • 10.2 EUROPE PERFUSION IMAGING MARKET
    • 10.2.1. Germany
    • 10.2.2. U.K.
    • 10.2.3. France
    • 10.2.4. Italy
    • 10.2.5. Spain
    • 10.2.6. Rest of Europe
  • 10.3 ASIA PACIFIC PERFUSION IMAGING MARKET
    • 10.3.1. China
    • 10.3.2. Japan
    • 10.3.3. India
    • 10.3.4. Rest of Asia-Pacific
  • 10.4 REST OF THE WORLD PERFUSION IMAGING MARKET

11 PERFUSION IMAGING MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 PERFUSION IMAGING MARKET OPPORTUNITIES

13 PERFUSION IMAGING MARKET TRENDS & INSIGHTS

14 DEMAND AND SUPPLY SIDE ANALYSIS

  • 14.1. Demand Side Analysis
  • 14.2. Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 PRICING ANALYSIS

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1 Porter's Five forces analysis

18 COMPANY PROFILED

  • 18.1. Siemens Healthineers
  • 18.2. GE Healthcare,
  • 18.3. Philips Healthcare
  • 18.4. Bayer AG
  • 18.5. Medtronic
  • 18.6. Canon Medical Systems Corporation
  • 18.7. Shimadzu Corporation
  • 18.8. Bracco Imaging S.p.A
  • 18.9. Neusoft Corporation
  • 18.10. Perimed AB

19 DISCLAIMER